Wanda Sharif-Rodriguez

Statistics

Publications

Citations

556

H-Index

Active since

2006

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Wanda Sharif-Rodriguez is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, renal physiology, and renal pathophysiology.

Publications per year

2006–2016

Publications

Torcetrapib‐induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone

M J Forrest, Daniel M. Bloomfield, Richard J. Briscoe et al. · British Journal of Pharmacology · 2008 · 288 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Murine CXCR1 Is a Functional Receptor for GCP-2/CXCL6 and Interleukin-8/CXCL8

Xuedong Fan, Andriani C. Patera, Amy Pong-Kennedy et al. · Journal of Biological Chemistry · 2006 · 207 citations · Full text

Life Sciences, Immunology, Molecular Biology +9

Heterozygous Disruption of Renal Outer Medullary Potassium Channel in Rats Is Associated With Reduced Blood Pressure

Xiaoyan Zhou, Zuo Zhang, Myung K. Shin et al. · Hypertension · 2013 · 31 citations · Full text

Medicine, Molecular Genetics, Physiology +17

Chronic Inhibition of Renal Outer Medullary Potassium Channel Not Only Prevented but Also Reversed Development of Hypertension and End-Organ Damage in Dahl Salt-Sensitive Rats

Xiaoyan Zhou, Michael J. Forrest, Wanda Sharif-Rodriguez et al. · Hypertension · 2016 · 19 citations

Medicine, Nephrology, Pharmacology +17

Chronic Antagonism of the Mineralocorticoid Receptor Ameliorates Hypertension and End Organ Damage in a Rodent Model of Salt-Sensitive Hypertension

Xiaoyan Zhou, Martin F. Crook, Wanda Sharif-Rodriguez et al. · Clinical and Experimental Hypertension · 2011 · 11 citations · Full text

Medicine, Pharmacology, Physiology +17

1–5 of 5